Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Keri Lotion is an over-the-counter topical emollient moisturizer used for symptomatic relief of dry, rough, scaly, and itchy skin and minor skin irritation. It is a multi-ingredient lotion formulation that commonly includes moisturizing and skin-conditioning components such as mineral oil, glycerin, tocopheryl acetate, sunflower seed oil, and aloe barbadensis leaf juice. Its effect is not mediated through a discrete pharmacologic target; rather, it works by forming an occlusive layer that reduces transepidermal water loss while humectant components help retain water in the stratum corneum, improving skin hydration and barrier function. It is marketed as a consumer skin-care product rather than a prescription therapeutic and has been sold in multiple formulations including original, shea butter, and fragrance-free variants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Keri Lotion.